Media Outlets Examine Safety, Effectiveness Of Malaria Drug Touted By Trump As Treatment For COVID-19, Used To Treat Other Ailments

CNN: President Trump is wrong in so many ways about hydroxychloroquine studies. Here are the facts (Cohen/Nigam, 4/11).

Financial Times: Trump’s malaria drug hope: ‘game changer’ or dangerous gamble? (Kuchler, 4/14).

Forbes: Trump’s Hydroxychloroquine Focus Causes A Shortage For Others (Sarkis, 4/13).

New York Times: Small Chloroquine Study Halted Over Risk of Fatal Heart Complications (Thomas/Sheikh, 4/12).

Washington Post: How false hope spread about hydroxychloroquine to treat covid-19 — and the consequences that followed (Samuels/Kelly, 4/13).

Washington Post: Anti-malarial drug touted by Trump was subject of CIA warning to employees (Barrett, 4/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.